Abel's Berkshire Debut Meets a Market Running on Fumes

“The people who changed your life the most probably have no idea they did it. Maybe tell one of them today.”

The S&P closed at a second consecutive record on narrowing breadth, Berkshire Hathaway held its first annual meeting under CEO Greg Abel, and Iran's latest peace proposal drew a "not satisfied" from Trump as a bulk carrier was attacked near Hormuz for the first time in weeks. The week ahead brings the April jobs report on Friday with forecasters projecting just 50,000.

Checking for audio...

S&P

—

NDX

—

DOW

—

BTC

—

ETH

—

SOL

—

Gold

—

Oil

—

10Y

—

Markets minute

Fewer than 30% of Nasdaq constituents advancing at a record high means this rally is a concentration trade, not broad confirmation. BTC at $78K with exchange reserves at seven-year lows signals accumulation under a ceiling that breaks with less volume each attempt. Brent's reversal from $105 on the Hormuz attack confirms the war premium is structural until escorts prove otherwise. Gold posting a weekly loss while oil stays elevated is the stagflation tell: inflation suppressing the safe-haven bid.

Today's signals

The Strait Opens Monday. Under Whose Flag Is the Question. A bulk carrier was attacked near Hormuz on May 3, the first maritime strike in weeks, hours after Trump announced "Project Freedom," a plan to begin escorting ships through the strait starting Monday. Iran had just submitted an updated peace proposal separating Hormuz reopening from nuclear negotiations. Trump declared himself "not satisfied." The binary risk is concentrated in Monday's first escort transit: if Iran challenges a convoy, Brent reprices above $120 within hours. If the escort passes unchallenged, the strait functionally reopens under US military guarantee. Either outcome reshapes the energy premium the market is treating as temporary. Jet fuel is up 95% since the war began, diesel up 49%, fertilizer up 31%. The ceasefire framework is now on its third exchange without resolution. Pakistan confirmed its mediating role, Turkey continues positioning as a competing intermediary, and the proliferation of mediators typically signals performance over substance. If no framework agreement emerges before the May 15 FOMC, the market must price simultaneous monetary and geopolitical risk.

geopolitics

The S&P's Record High Is Running on Five Stocks and an Accounting Trick April's 10.4% monthly gain, the best in five years, masked the narrowest breadth since January 2020. Fewer than 30% of Nasdaq constituents are advancing while mega-cap tech carries the entire move. The Russell 2000 and mid-caps lag by 300-500bp. This is a stagflation rotation signature: capital fleeing duration-sensitive and credit-sensitive names for the perceived safety of cash-rich mega-caps. The headline says "all-time high" while the composition says "narrowing leadership approaching cyclical peak." Meanwhile, Jim Chanos identified a structural EPS inflation mechanism nobody is discussing. Hyperscalers are spending $600-700B in AI capex this year, capitalized over 5-7 years, meaning only $85-140B appears as annual depreciation. But that same spend shows as immediate revenue for NVIDIA, TSMC, memory manufacturers, and power equipment suppliers. The market is trading on earnings mechanically inflated by the temporal gap between cash leaving one balance sheet and appearing on another. The telecom sector in 1999-2001 exhibited the identical pattern: supplier revenue looked extraordinary until capex merely plateaued, not collapsed, and the accounting unwound faster than the business deteriorated. The counter-case: unlike WorldCom, today's spenders are self-funded with $400B+ in combined free cash flow, and if AI demand doubles annually, the mismatch never unwinds. But if capex growth merely moderates from 40% to 15% in 2027, supplier revenue mechanically decelerates by more than underlying demand would suggest.

ai · tech

North Korea Ran a Six-Month Intelligence Operation Inside DeFi The Drift Protocol hack was not a code exploit. North Korean operatives spent six months attending conferences, depositing over $1M of their own capital, and building real relationships before deploying malicious code. The attack surface is not smart contracts. It is humans. When nation-states run intelligence operations against crypto protocols, the defense shifts from code audits to counterintelligence, a capability no protocol currently has. The protocols with institutional infrastructure (Aave holds 59.8% lending share, $35.4M monthly revenue, SEC investigation cleared) can absorb this. The fully open ones become targets. Expect this bifurcation to get priced as Consensus 2026 opens in Miami this week with the GENIUS Act stablecoin framework and CLARITY Act as headline regulatory catalysts. If both advance through committee by July, the regulatory uncertainty discount on DeFi tokens reprices significantly.

crypto · defi

Sovereign AI Just Died in Europe Cohere acquired Germany's Aleph Alpha, the EU's most prominent sovereign AI company, which had raised half a billion euros from German state-backed investors to build a European alternative to US models. A Canadian company buying Europe's champion AI lab ends that experiment decisively. The structural lesson: AI model development requires capital at a scale that European venture and state investment cannot sustain against US and Chinese competitors spending tens of billions annually. If Cohere integrates Aleph Alpha's government contracts and data sovereignty architecture, it becomes the default AI provider for European defense and government applications, a moat no other non-US company can replicate. The pattern mirrors what happened to European cloud infrastructure a decade ago: ambition without scale capital produces acquisition targets, not competitors.

ai · tech

China Just Made It Illegal to Comply with US Sanctions Beijing activated its blocking statute for the first time on May 2, ordering all Chinese firms and individuals to refuse compliance with US sanctions on five Chinese oil refineries buying Iranian crude. The sanctioned entities include Hengli Petrochemical (Dalian) and four Shandong-based refineries, all added to the US SDN List in late April. Any multinational operating in both jurisdictions now faces a legal impossibility: complying with US secondary sanctions means violating Chinese law, and vice versa. Trade law professor Henry Gao's assessment: "The decoupling is coming." This arrived 12 days before Trump visits Beijing, making it a negotiating signal rather than an accident. But the template extends far beyond oil. Global banks with dollar clearing operations and Chinese counterparties (HSBC, Standard Chartered, JPMorgan Asia) must choose which legal system to obey. If China activates the statute a second time this year on semiconductors or rare earths, expect corporate compliance costs to spike as companies build parallel legal and operational structures for US-aligned and China-aligned business.

geopolitics

Interesting things

One Protein. That's It. Cognitive Decline Reversed in Mice.

UCSF researchers identified FTL1, a single protein that accumulates in the hippocampus with age. When they reduced it in old mice, memory function restored. Not slowed. Reversed. One protein, one mechanism, testable in humans. Not a "brain health" supplement claim. A specific, targetable intervention with a clear biological pathway. If human trials confirm the mechanism, this becomes the most direct and specific route to treating age-related cognitive decline ever identified.

A Personalized Cancer Vaccine Just Hit Three-Year Durability

A clinical trial in The Lancet Oncology showed a personalized mRNA vaccine (BioNTech/Genentech) reduced melanoma recurrence by 44% over three years when combined with immunotherapy. The vaccine is custom-built for each patient using their tumor's genetic profile, targeting up to 34 neoantigens. BioNTech has 15 mRNA cancer vaccine trials active across pancreatic, colorectal, and lung cancers. If two more show comparable efficacy, mRNA transitions from "COVID platform" to "programmable immune system platform."